Physician profile
Kaitlin Daniel
NPI 1639848476
$445.67
in general payments reported to CMS, 2019-2025
13 companies · $169 in 2025
The $169 reported for 2025 was less than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $41.90 · 2024: $235 · 2025: $169.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $446.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $445.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $77.32 | 2024 | |
| Glaxosmithkline, LLC. | $54.19 | 2025 | Bexsero, Arexvy, Shingrix |
| Alk-Abello, INC | $49.83 | 2023-2025 | Neffy, Grastek, Odactra |
| Globus Medical, INC. | $41.67 | 2025 | Senza |
| Dexcom, INC. | $40.63 | 2024 | Dexcom G6 Transmitter |
| Abbvie INC. | $31.70 | 2024 | |
| Exact Sciences Corporation | $30.39 | 2025 | The Cologuard Plus Collection Kit |
| Ironshore Pharmaceuticals INC. | $29.12 | 2024 | |
| Verrica Pharmaceuticals INC. | $20.92 | 2024 | Ycanth |
| Nevro Corp. | $19.76 | 2024 | Senza |
| Tris Pharma INC | $19.30 | 2023 | Dyanavel Xr |
| Neos Therapeutics, LP | $15.53 | 2024 | Cotempla Xr-Odt |
| Lnhc, INC | $15.31 | 2025 | Zelsuvmi |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kaitlin Daniel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.